NCT00160381View on ClinicalTrials.gov

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids

PHASE3CompletedINTERVENTIONAL

Enrollment

432

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions

LeiomyomaMenorrhagiaMetrorrhagia

Interventions

DRUG

Asoprisnil

10mg Tablet, oral Daily for 12 months

DRUG

Asoprisnil

25 mg Tablet, oral Daily for 12 months

DRUG

Placebo

Tablet, oral Daily for 12 months

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Abbott

INDUSTRY